Organization | Islamia University of Bahawalpur

Islamia University of Bahawalpur Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2020

NCT04575493

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Islamia University of Bahawalpur

Active Ingredients

Drugs in Other Trials (6)

ciprofloxacin (cipro) (1 trial)

cumin (1 trial)

piper cubeba fruit (1 trial)

rheum emodi (1 trial)

tribulus terrestris root (1 trial)

vaccinium macrocarpon (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 1
# of Trial APIs: 6